Besides counteraction of bleeding aspirin-gastric ulcers (14), BPC 157 also counteracts other NSAIDs-toxicity, using the same dose range (8-14), namely, gastric and small intestine ulcers (i.e., induced by indomethacin, diclofenac, ibuprofen, celecoxib (8-14)), hepatotoxicity (paracetamol, diclofenac, ibuprofen, celecoxib) (8-14) and encephalopathy (paracetamol, diclofenac, ibuprofen, celecoxib) (8-14)
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2 trial (Lancet Diabetes & Endocrinology)
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Transitioning between vials When your current vial runs low and you open a new one, maintain the same concentration
TB-500 costs TB-500 pricing runs slightly higher than BPC-157 due to its longer amino acid sequence and more complex synthesis requirements